Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 9Completed 8Recruiting 5Terminated 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 39INDUSTRY 24NETWORK 7NIH 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Paclitaxel 2Irinotecan 2Carboplatin 2pertuzumab 1ledipasvir 1genexol-PM 1elbasvir-grazoprevir drug combination 1dolutegravir 1apatinib 1Vinorelbine 1Trastuzumab 1Tissue Banks 1Tai Ji 1Surgical Procedures, Operative 1Sofosbuvir 1S 1 (combination) 1Ritonavir 1Ribavirin 1Radiotherapy, Intensity-Modulated 1Qigong 1Physical Examination 1Oxaliplatin 1Nucleosides 1Nivolumab 1Magnesium 1Levoleucovorin 1Interleukin-2 1Immunotherapy 1Immune Checkpoint Inhibitors 1Hydralazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Fluorouracil × Clear all
NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Fujian Cancer Hospital

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡